Osteoarthritis (OA) affects over 650 million people worldwide, placing a significant burden not only on individuals but also on healthcare systems.
Current treatment approaches primarily focus on managing symptoms — pain relief, physical therapy, and eventually, joint replacement surgery.
While these methods may offer temporary relief, they do not address the root cause of OA or stop its progression.
But is that really enough?
The reality is that millions of patients remain trapped in a cycle of chronic pain and reduced mobility, with no definitive solution in sight.
Overreliance on pain medication also raises the risk of drug dependency and serious health complications.

It’s time for a new direction
We need a breakthrough therapy that targets the underlying mechanical dysfunction of the joints — the true cause of osteoarthritis.
By investing in research and embracing innovative solutions like REGENOGEL, we can create a brighter future for those living with OA - REGENOGEL.
Patients deserve more than temporary relief — they deserve a life that’s pain-free, active, and fulfilling.